Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
58 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
OLIPHARM from Ukkel, company number BE0840562012, closed financial year 2025 with a result of € 3,720 after tax. For that financial year OLIPHARM recorded a gross margin of € 4,204 and equity of € 143,156. Compared with financial year 2024, the result moved from € -423 to € 3,720. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 143,156
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,720
▲ still € 423 loss in 2024
Profit after tax over the fiscal year.
€ 5,429
▼ 42% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 107,044.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,563
Supplier invoices still open on the last day of the fiscal year.
€ 1,526
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 5,986 | € 55,270 | € -2,995 | € 4,204 | ▲ € 7,199 |
| Profit after taxes | € 6,018 | € 44,104 | € -423 | € 3,720 | ▲ € 4,143 |
| Equity | € 81,823 | € 139,860 | € 139,437 | € 143,156 | ▲ 3% |
| Total debts | € 1,155,800 | € 1,168,045 | € 1,168,045 | € 1,166,763 | |
| Cash | € 4,258 | € 14,664 | € 9,338 | € 5,429 | ▼ 42% |
| Retained profit | € 59,643 | € 103,748 | € 103,325 | € 107,044 | ▲ 4% |
| Balance sheet total | € 1,237,623 | € 1,307,905 | € 1,307,481 | € 1,309,920 |
Key figures of OLIPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OLIPHARM?
What happened at OLIPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3,720. Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,018 profit in 2022 to € 3,720 profit in 2025.
Paid € 14,671 in corporate taxes since 2022.
Best year ever: 2023, with € 44,104 profit.
A new publication or filing at OLIPHARM? We notify you, reason included.
Follow OLIPHARMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind OLIPHARM is LOSANE. It owns 33.9% of L.D Finances SRL, 33% of Pâtisserie Wittamer & CO SA, 20% of Inside Investment Funds SRL, 18% of Bell Tower SRL, 15% of House5 SRL and 15% of Chevremont Development SRL itself.
Directors
According to the 2025 annual accounts
Director · represented by Carlos de Meester de Betzenbroeck
Also active at: Pâtisserie Wittamer et Co, Compagnie EUTHERPE, SUNRISE - LATERALE, IMMOBILIERE GRANT ET COMPAGNIE, IMMO SABLON SAINTE-ANNE, L.D. FINANCES, Matigès, CENTRUM INVEST +40 more
Establishments
Establishment units
Physical locations of this company
Lijsterbessebomenlaan 25
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 58 companies are registered at this address.
All companies at this address →Société civile centre médical Meiser
€ 53,376 gross margin · 2025
SICOVER
€ -1,291 gross margin · 2025
Compagnie EUTHERPE same network
€ 32,186 gross margin · 2025
SUNRISE - LATERALE same network
€ 5,642 gross margin · 2025
IMMOBILIERE GRANT ET COMPAGNIE same network
€ 560,301 gross margin · 2025
+53 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0840.562.012
- VAT number
- BE 0840.562.012
- Registered office
- Lijsterbessebomenlaan 25, 1180 Ukkel
- Names & denominations
- OLIPHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 October 2011
- Peppol
- Active · Active since 26 Sept 2025
- Activities · NACE
Ontwikkeling van residentiële bouwprojecten
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Ontwikkeling van niet-residentiële bouwprojecten
Verhuur en exploitatie van terreinen
Bemiddeling in verband met exploitatie van en handel in onroerend goed
Handel in eigen onroerend goed
Bemiddeling bij de aankoop, verkoop en verhuur van onroerend goed voor een vast bedrag of op contractbasis